{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006810",
      "entity_text" : "transport",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5287620",
      "entity_text" : "brefeldin A",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "After 24h, vesicle transport inhibitors brefeldin A (BioLegend) and Golgi Stop (BD Biosciences) were added the culture media following the manufacturer 's instructions and cells were cultured for 5 additional h. Subsequently, cells were washed with 1x PBS and intracellular expression of IL-12 and IL-6 in CD14 - CD11c Hi HLADR + mDCs and CD14 + Monocytes was evaluated by flow cytometry.",
  "reading_complete" : "2020-08-08T14:40:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:37:02Z",
  "trigger" : "inhibitors",
  "evidence" : [ "transport inhibitors brefeldin A" ],
  "pmc_id" : "6990401",
  "score" : 0
}